NCT02287298View on ClinicalTrials.gov

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Exudative Macular Degeneration

Interventions

PROCEDURE

TRIPLE COMBINATION THERAPY

TREATMENT WITH BEVACIZUMAB, DEXAMETHASONE AND PHOTODYNAMIC THERAPY

Trial Locations (1)

63141

The Retina Center, St Louis

All Listed Sponsors

lead

The Retina Center of St. Louis County, PC

OTHER

NCT02287298 - Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment | Biotech Hunter | Biotech Hunter